Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience.
  • Home
  • About Us
    • Management Team
    • Board of Directors
  • Products in Development
    • Intermezzo®
  • Investors
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
    • Analysts
    • Shareholder Tools
      • Shareholder Briefcase
      • Printed Materials
      • Email Alerts
  • Careers
  • Contact
 
 

News & Events

    Monday, December 14, 2009

    Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)

    Monday, November 23, 2009

    Transcept Pharmaceuticals Scheduled to Meet With FDA to Discuss Intermezzo(R) Complete Response Letter

    Thursday, November 12, 2009

    Transcept Pharmaceuticals Reports Third Quarter 2009 Financial Results

    Tuesday, November 10, 2009

    Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17

Transcept Stock Quote
Copyright © 2010  |  
Sitemap  |  Contact Us